Labetalol can be used for pheochromocytoma, but cautiously. It blocks alpha and beta receptors, reducing hypertension risks but can cause severe rebound hypertension.

Labetalol is used in pheochromocytoma for its dual-action on alpha and beta-adrenergic receptors, aiding blood pressure control, but careful monitoring is essential to manage potential adverse effects.